Related references
Note: Only part of the references are listed.Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study
Naoto Adachi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2021)
The costs of bipolar disorder in the United Kingdom
Judit Simon et al.
BRAIN AND BEHAVIOR (2021)
Direct incremental healthcare costs associated with mood disorders in the United States, 2007?2017
Hammad A. Khan et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder
Keita Tokumitsu et al.
BMC PSYCHIATRY (2020)
Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI)
Masaki Kato et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder
Norio Yasui-Furukori et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2020)
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Leona Bessonova et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2020)
Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia
Irma M. Puspitasari et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)
Takashi Tsuboi et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)
Clinical characterization of rapid cycling bipolar disorder: Association with attention deficit hyperactivity disorder
Alberto Aedo et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Utility of functioning in predicting costs of care for patients with mood and anxiety disorders: a prospective cohort study
Conal Twomey et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2017)
Update on the Epidemiology, Diagnosis, and Treatment of Mania in Older-Age Bipolar Disorder
Peijun Chen et al.
CURRENT PSYCHIATRY REPORTS (2017)
Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia
Ole Kohler et al.
CLINICAL EPIDEMIOLOGY (2016)
Cost-of-Illness Studies for Bipolar Disorder: Systematic Review of International Studies
Huajie Jin et al.
PHARMACOECONOMICS (2015)
Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study
Luca Degli Esposti et al.
BMC PSYCHIATRY (2014)
Costs of the principal mood disorders: A study of comparative direct and indirect costs incurred by those with bipolar I, bipolar II and unipolar disorders
Gordon Parker et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Bipolar disorder and socioeconomic status: what is the nature of this relationship?
Laeticia Eid et al.
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2013)
Cost of depression among adults in Japan in 2005
Mitsuhiro Sado et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
Monica Tafalla et al.
BMC PSYCHIATRY (2010)
Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Programme
Ying Qiu et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2010)
Health and Economic Burden of Metabolic Comorbidity Among Individuals With Bipolar Disorder
Franca Centorrino et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Share Paper
